http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5677300-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afd115dec46c157d3739020ebd4d866b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9fa13c33b79ba86e25d61d5e3cee4f2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 |
| filingDate | 1996-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1997-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a4c5bd7fdf5dfa99b0804332fa4a15b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93c1c566208b6bccfed115ddb851869b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ab3f8512e8310afefa89d1e94fb8e8a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b076e44c00b036fb5cce73284e3f8346 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b67d131f69c8fe016e1a707bc008b0b8 |
| publicationDate | 1997-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5677300-A |
| titleOfInvention | Pyridothiazineacetic acid compound, production thereof and use thereof |
| abstract | A pyridothiazineacetic acid compound of the formula (I) <IMAGE> (I) wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof, production thereof, and a pharmaceutical composition, an aldose reductase inhibitor and a preparation for the prevention and treatment of the complications of diabetes, containing the same. The pyridothiazineacetic acid compound and a pharmaceutically acceptable salt thereof of the present invention have an aldose reductase inhibitory action and are superior in safety. Accordingly, they are useful as a preparation for the prevention and treatment of the complications of diabetes, such as faulty union of corneal injury, cataract, neurosis, retinopathy and nephropathy, particularly, cataract and neurosis. In addition, the production method of the present invention enables efficient production of said pyridothiazineacetic acid compound. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008233053-A1 |
| priorityDate | 1993-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 127.